Triazolopyrazinone derivative useful as a human PDE1 inhibitor
- 专利权人:
- Eli Lilly and Company
- 发明人:
- Mark David Rekhter,Qing Shi
- 申请号：
- US15680250
- 公开号：
- US10138244B2
- 申请日:
- 2017.08.18
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention provides a compound of Formula I:or a pharmaceutically acceptable salt thereof, for use as a human PDE1 inhibitor.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- TRIAZOLOPYRAZINONE DERIVATIVE WHICH CAN BE USED AS A HUMAN PDE1 INHIBITOR
- TRIAZOLOPYRAZINONE DERIVATIVE USEFUL AS A HUMAN PDE1 INHIBITOR
- TRIAZOLOPYRAZINONE DERIVATIVE USEFUL AS A HUMAN PDE1 INHIBITOR
- DERIVATIVE TRIAZOLOPYRAZINONE USED AS A HUMAN PDE1 INHIBITOR
- Triazolopyrazinone derivatives useful as human PDE1 inhibitors
